tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

UNCY Stock Latest News

Unicycive Therapeutics: Buy Rating Backed by Promising OLC Progress and Strategic Market Positioning
RatingsUnicycive Therapeutics: Buy Rating Backed by Promising OLC Progress and Strategic Market Positioning
1M ago
UNCY
Unicycive Therapeutics Doubles Stock Sale Agreement
PremiumCompany Announcements
Unicycive Therapeutics Doubles Stock Sale Agreement
1M ago
8K
UNCY
Positive Outlook for Unicycive Therapeutics Amidst Promising Developments and Financial Stability
PremiumRatings
Positive Outlook for Unicycive Therapeutics Amidst Promising Developments and Financial Stability
1M ago
UNCY
Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)
PremiumThe Fly
Unicycive Therapeutics reports Q3 EPS (46c), consensus (53c)
1M ago
UNCY
Unicycive Therapeutics sees cash runway into 2027
PremiumThe Fly
Unicycive Therapeutics sees cash runway into 2027
1M ago
UNCY
Ten new option listings on November 5th
PremiumThe FlyTen new option listings on November 5th
1M ago
AIS
DRTS
Optimistic Buy Rating for Unicycive Therapeutics Driven by Promising Clinical Progress and Financial Stability
Premium
Ratings
Optimistic Buy Rating for Unicycive Therapeutics Driven by Promising Clinical Progress and Financial Stability
2M ago
UNCY
Unicycive Therapeutics to present new OLC data at ASN Kidney Week 2025
Premium
The Fly
Unicycive Therapeutics to present new OLC data at ASN Kidney Week 2025
2M ago
UNCY
Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright
PremiumThe Fly
Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright
2M ago
UNCY
Unicycive Therapeutics Updates FDA Application for OLC
PremiumCompany Announcements
Unicycive Therapeutics Updates FDA Application for OLC
2M ago
8K
UNCY
Unicycive provides update on meeting with FDA, resubmission of NDA for OLC
PremiumThe Fly
Unicycive provides update on meeting with FDA, resubmission of NDA for OLC
2M ago
UNCY
UNCY Lawsuit Alert! Class Action Lawsuit Against Unicycive Therapeutics
PremiumMarket News
UNCY Lawsuit Alert! Class Action Lawsuit Against Unicycive Therapeutics
3M ago
UNCY
Unicycive Therapeutics price target adjusted at Benchmark after reverse split
PremiumThe FlyUnicycive Therapeutics price target adjusted at Benchmark after reverse split
3M ago
UNCY
Unicycive Faces Class Action Over FDA Misleading Claims
Premium
Class Action
Unicycive Faces Class Action Over FDA Misleading Claims
4M ago
UNCY
Unicycive Faces Securities Lawsuit Over Drug Claims
Premium
Company Announcements
Unicycive Faces Securities Lawsuit Over Drug Claims
4M ago
8K
UNCY
Unicycive Therapeutics granted new U.S. patent for UNI-494 to treat CKD
PremiumThe Fly
Unicycive Therapeutics granted new U.S. patent for UNI-494 to treat CKD
4M ago
UNCY
Unicycive Therapeutics Raises $16.3 Million in Stock Sale
PremiumCompany Announcements
Unicycive Therapeutics Raises $16.3 Million in Stock Sale
4M ago
8K
UNCY
Unicycive Therapeutics: Buy Rating Amid FDA Compliance Resolution and Strong Financial Position
PremiumRatings
Unicycive Therapeutics: Buy Rating Amid FDA Compliance Resolution and Strong Financial Position
4M ago
UNCY
Unicycive Therapeutics reports Q2 EPS (52c), consensus (70c)
PremiumThe Fly
Unicycive Therapeutics reports Q2 EPS (52c), consensus (70c)
4M ago
UNCY
Unicycive Therapeutics requests Type A meeting with FDA to discuss CRL
PremiumThe FlyUnicycive Therapeutics requests Type A meeting with FDA to discuss CRL
4M ago
UNCY
Unicycive Therapeutics expects cash to fund operations into 2H of 2026
Premium
The Fly
Unicycive Therapeutics expects cash to fund operations into 2H of 2026
4M ago
UNCY
Unicycive Therapeutics announces publication of OLC trial data
Premium
The Fly
Unicycive Therapeutics announces publication of OLC trial data
5M ago
UNCY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >